EPHA2 and glioblastoma: Furthermore, data from bioinformatical analyses have implicated that ANAX1, CYR61, and VIM are mainly associated with the development of PAAD and GBM, while CEACAM1 and EPHA2 are associated with adrenocortical carcinoma.